Scholars@Duke

3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells

Publication ,  Journal Article
Vaidyanathan, G; Zhao, X-G; Larsen, RH; Zalutsky, MR
Published in: British Journal of Cancer
July 1997
Published version (DOI) Publisher Link

Duke Scholars

Ganesan Vaidyanathan
Author Ganesan Vaidyanathan Radiology
Michael Rod Zalutsky
Author Michael Rod Zalutsky Radiology

Published In

British Journal of Cancer

DOI

10.1038/bjc.1997.366

EISSN

1532-1827

ISSN

0007-0920

Publication Date

July 1997

Volume

76

Issue

2

Start / End Page

226 / 233

Publisher

Springer Science and Business Media LLC

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1117 Public Health and Health Services
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vaidyanathan, G., Zhao, X.-G., Larsen, R. H., & Zalutsky, M. R. (1997). 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells. British Journal of Cancer, 76(2), 226–233. https://doi.org/10.1038/bjc.1997.366
Vaidyanathan, G., X. -. G. Zhao, R. H. Larsen, and M. R. Zalutsky. “3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.” British Journal of Cancer 76, no. 2 (July 1997): 226–33. https://doi.org/10.1038/bjc.1997.366.
Vaidyanathan G, Zhao X-G, Larsen RH, Zalutsky MR. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells. British Journal of Cancer. 1997 Jul;76(2):226–33.
Vaidyanathan, G., et al. “3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.” British Journal of Cancer, vol. 76, no. 2, Springer Science and Business Media LLC, July 1997, pp. 226–33. Crossref, doi:10.1038/bjc.1997.366.
Vaidyanathan G, Zhao X-G, Larsen RH, Zalutsky MR. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells. British Journal of Cancer. Springer Science and Business Media LLC; 1997 Jul;76(2):226–233.

Published In

British Journal of Cancer

DOI

10.1038/bjc.1997.366

EISSN

1532-1827

ISSN

0007-0920

Publication Date

July 1997

Volume

76

Issue

2

Start / End Page

226 / 233

Publisher

Springer Science and Business Media LLC

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1117 Public Health and Health Services
  • 1112 Oncology and Carcinogenesis